HBV Mutation Detail Information

> T1753C Search Result

Mutation Information

Mutation Site	T1753C
Mutation Type	Nucleotide level
Gene/Protein/Region Type	C Promoter
Genotype/Subtype	D

Literature Information

PubMed PMID	16197491
Disease	Chronic hepatitis B
Published Year	2005
Journal	Alimentary pharmacology & therapeutics
Title	Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis.
Author	Marrone A,Zampino R,Karayannis P,Cirillo G,Cesaro G,Guerrera B,Ricciotti R,del Giudice EM,Utili R,Adinolfi LE,Ruggiero G
Evidence	The T1753C mutation was detected in seven of eight patients (87%) in group A and in none from group B1 (P = 0.004) or group B2 (P = 0.0004).

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation